This story about the recent academic paper from Germany identifying enzymes that create psilocybin ran in the Smithsonian. It follows this story from Newsweek. Name recognition-level awareness of psilocybin is taking place in the mainstream newsmedia to an unprecedented degree. The Smithsonian and Newsweek articles are a counterweight to the steady stream of shrooms-and-crime stories… Read More Psychedelic cross-over
Sessions’ comment is a total non sequitur, a decoy. The AG is fully-empowered to take action to review the status of cannabis under federal law. Put the questions to him.
The FDA and the DEA abandoned the “gateway theory” in August 2016 Newsflash: the “gateway theory” is no longer official government doctrine There is much concern in the cannabis legalization movement/industry that the new administration will go to war against the legal cannabis markets. The nomination of Alabama Senator Jeff Sessions, recent comments… Read More Vaporizing cannabis prohibition: the gateway theory is gone
Gonzalez Franco predicted technology would allow users to experience mind-altering hallucinations that often occur under the influence of psychedelic drugs but without all the dismal side effects of taking a substance like LSD. from an International Business Times article on a new product line from Microsoft. Dismal side effects of taking a substance like LSD. Like…a lower… Read More Virtual reality and psychedelic prohibition
Change federal drug law to require that the DEA consider whether states accept that there is a medical use for cannabis Back in October of 2012 I published an explanation of the DEA’s legal justification for permanent cannabis prohibition and how to attack it. I explained that the DEA misconstrues the Controlled Substances Act (the “CSA”), the federal statute that governs… Read More Vaporizing cannabis prohibition under Trump: make the DEA defer to state law
The following video is relevant to people who advocate for psychedelic legalization. Cannabis lawyer Hilary Bricken posits that (a) state-level regulatory factors have given rise to “Big Marijuana,” the for-profit industry that requires deep capitalization and therefore monopoly (functional or actual) and (b) the prohibitionist movement (which is not dead, just dormant waiting for the opportunity to reassert… Read More Big Acid
The Imperial College of London just announced that a small safety trial of twelve patients with moderate to severe treatment-resistant depression shows that psilocybin can be administered safely and can relieve symptoms of depression for up to five months. The article states that 350 million people around the world (that’s all?) suffer from depression. Other than safety the purpose of… Read More Psychedelic prohibition as restraint-of-trade: results from a limited trial of psilocybin for treatment-resistant depression